Energy Fuels (NYSE American: UUUU) (TSX: EFR) has partnered with Neo Performance Materials (TSX: NEO) in an initiative that will see feedstock from the United States being used to manufacture separated rare earth (“RE”) materials outside China for the first time in over 20 years. “A leading U.S.-based uranium mining company, Energy Fuels, has been working with Neo for almost a year in a technical collaboration focused on establishing a monazite processing and RE carbonate production capacity at Energy Fuels’ White Mesa Mill plant in Utah,” reads an article detailing the partnership. “That successful collaboration has led to the current initiative, which marks the first time in more than 20 years that monazite ore from the United States will be used as a feedstock to manufacture separated rare earth materials outside of China. The agreement calls for Energy Fuels to process natural monazite sands, which it obtains from the Chemours Company (NYSE: CC), into an RE carbonate beginning next year and ship a portion of that production to Neo’s rare earth separation facility in Estonia.”
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest N.I. 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts
Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care
With explosion of telemedicine services and increased integration of advanced practice providers, neurologists’ shortage may improve
Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge technologies. By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool.
Between 2001 and 2016, the American Academy of Neurology (“AAN”) reported that out-of-pocket costs shot up substantially for privately insured patients. In addition, the distribution of neurologists across the U.S. is uneven, with patients in rural areas less likely to receive care (https://ibn.fm/9sUYR). There are 20 states, according to the 2017 Alzheimer’s Association International Conference, classified as neurology deserts (https://ibn.fm/cGx2k). This term designates an area that has projected a chronic shortage of neurologists alongside a rise in dementia cases.
“In many places, people do not have easy access to specialists, for a variety of reasons. But you may not need a neurologist in every case,” said Beth Kallmyer, MSW, vice president of Constituent Services at the Alzheimer’s Association. “With the right training and tools, primary care physicians can effectively diagnose and treat Alzheimer’s disease. The Alzheimer’s Association is working to arm primary care physicians with the tools they need to manage an increased caseload, as well as care planning guidance.”
Brain Scientific has developed tools that provide primary care physicians in neurology deserts the ability to serve their patients and create specialized treatment plans that provide access to neurologists. Portable, clinical-grade, easy-to-use diagnostic devices are now in place to allow to run EEG tests withing a few minutes. The company is actively working on a secure, cloud-based and highly scalable infrastructure to transmit patient data between neurologists and patients as well as creating artificial intelligence assisted diagnostic analysis.
Currently, across the United States, there is significant disparity between who has access to neurology care and who does not. A MedPate Today article reported that the lowest density had a mean of 9.7 neurologists for every 100,000 Medicare beneficiaries while the highest had 43.1 neurologists for every 100,000 (https://ibn.fm/dGCud). While the number of conditions remained similar, the access to care did not. With the explosion of telemedicine services and an increased integration of advanced practice providers, neurologists’ shortage may just improve.
Through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers, Brain Scientific will create resources to narrow this wide gap. The company’s commercialized products were designed to disrupt the slow, expensive and cumbersome EEG market with easy-to-use, economical and disposable solutions. These devices are so easy to use that any medical professional can use them within minutes in any setting to run routine EEG studies.
Brain Scientific can potentially change the United States’ landscape and eliminate neurology deserts once and for all. It’s time everyone had access to the life-saving research available.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
A group of researchers from the Feinberg School of Medicine at Northwestern University has discovered additional evidence of cognitive dysfunction in many coronavirus patients who were not hospitalized after contracting the infection. The group’s findings were reported in the “Annals of Clinical and Translational Neurology” journal.
In the study, the researchers looked into medical data of nonhospitalized coronavirus patients from 21 different states who were experiencing long-term symptoms of the coronavirus, documenting what they discovered from the study.
As the pandemic surges on, despite measures to contain it, media outlets have continued to report statistics on the number of mortalities and number of coronavirus infections. However, not much attention has been paid to individuals who were harmed by the deadly virus but not enough to be hospitalized. This is why the team of researchers decided to unearth more information about some of the long-term effects experienced by individuals who had contracted the infection, which is caused by the SARS-CoV-2 virus.
To discover more information about these patients who are now commonly referred to as long haulers, the researchers acquired the data of 100 patients from medical institutions in 21 states; the patients had all contracted the coronavirus but were not admitted to hospital. Some of these patients were seen in person with many visiting the Northwestern Memorial Hospital, which is located in Chicago, while others opted for the telehealth option. The researchers noted that nearly half of the data obtained involved patients who hadn’t been diagnosed with the infection but were believed to have been infected with the virus.
The team of researchers discovered that about 85% of the patients studied in their research revealed that they had at least four neurological symptoms, the most common of which were found to be tingling, numbness, headaches and brain fog. Other symptoms the researchers found to be common were ringing in the ears, dizziness, blurred vision and the loss of smell and/or taste. The researchers also noted that most of these patients described these symptoms as on and off, with many of them revealing that their symptoms lasted for several months, with some lasting for as long as nine months.
Additionally, the researchers discovered that the majority of the patients they observed reported that they felt anxious or depressed prior to their infection, which may suggest an increased risk of long-haul symptoms for individuals with similar conditions.
The researchers admitted that while their study was small, it was big enough to demonstrate that long haulers could possibly need more care than many researchers and health-care providers realize.
Another group that needs more care are patients suffering from cystic fibrosis as well as chronic pancreatitis, particularly those who develop exocrine pancreatic insufficiency (aka EPI). AzurRx BioPharma Inc. (NASDAQ: AZRX) is conducting clinical trials on a drug candidate that could help EPI patients get relief.
NOTE TO INVESTORS: The latest news and updates relating to AzurRx BioPharma Inc. (NASDAQ: AZRX) are available in the company’s newsroom at https://ibn.fm/AZRX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), will be presenting at the Emerging Growth Conference this week. VVOS CEO Kirk Huntsman, along with chief financial officer Brad Amman and investor relations officer Ed Loew, will host the presentation, which is scheduled for Wednesday, April 14, at 9 a.m. EDT. Interested investors can obtain a free spectator pass. In addition, a replay of the presentation will be available on the Vivos website.
Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have proven effective in more than 18,000 patients treated worldwide by more than 1,200 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information about this company, visit www.VivosLife.com.
NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Splash Beverage Group (OTCQB: SBEV), a holding company of a leading portfolio of beverage brands, today announced its entry into a partnership with Better Brands, a South Carolina distributor of more than 50 years that works with brands like Corona, Sam Adams, Danica Rose, Chateau Diana and more. According to the update, Better Brands will distribute SBEV’s SALT Naturally Flavored Tequila throughout the Myrtle Beach region, a world-renowned golfers’ paradise that attracts over 19 million visitors annually. Better Brands currently has 19 sales reps, six managers and two key account managers (“KAMS”) and is expanding the sales force for SBEV brands in line with increased opportunity and demand. “As COVID-19 restrictions continue to lift, we are growing our seasoned team of sales professionals to maximize potential across our portfolio of brands. Splash Beverage Group is primed for expedited growth like never before,” said SBEV CEO Robert Nistico. “Currently, we are evaluating a number of high-profile target acquisitions and will continue to add more brands and expand our extensive network of distributors nationwide.”
Splash Beverage Group specializes in manufacturing, distribution, sales and marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it ONLY develops/accelerates brands it perceives to have highly visible preexisting brand awareness or pure category innovation. For more information about the company, visit www.SplashBeverageGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at http://ibn.fm/SBEV
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Last week, the New York City police department (“NYPD”) sent out an internal memo clarifying a number of issues after Gov. Andrew Cuomo signed a bill legalizing adult-use marijuana.
Among other things, the memo indicated that individuals who are at least 21 years old will no longer be liable for an arrest once they smoke marijuana in any place where people are allowed to smoke tobacco. Those places include sidewalks as well as other public spaces.
The police department also informed its officers that under the new marijuana law, adults were at liberty to gift cannabis to other adults as long as no payment or other form of compensation are given in return. The NYPD noted that, at the moment, it is still illegal to grow cannabis at home, but once enabling rules are published, no police officer will be at liberty to take any enforcement action unless someone is growing marijuana in ways that flout the home-grow rules, such as exceeding the number of plants permitted by law.
NYPD was unequivocal in its assertion that absolutely no one would be permitted to drive while under the influence of marijuana. However, police officers wouldn’t be allowed to cite the smell of burnt or unburnt marijuana as probable cause for enforcement action, such as searching a vehicle, arresting the driver or issuing a summons.
The NYPD memo goes on to spell out the exception to that rule. The department says enforcement action can justifiably be taken once a driver seems to be impaired and an officer suspects that the marijuana triggering the impairment is within the vehicle. Also, law enforcement officers can act when they observe a driver consuming (smoking) marijuana as they drive a vehicle.
It is also noteworthy that the memo makes reference to the possession of cannabis by minors. The agency clarifies that at the moment, there isn’t a mechanism that the police department can base upon to take action as long as the minor is found with less than the three ounces permitted for adults. In due course, a mechanism will be established to guide how marijuana possession by minors will be treated by the law enforcement community.
Individuals on parole are also mentioned in the internal memo. Officers were advised to desist from approaching or even detaining parolees who are in possession of legally permitted amounts of cannabis unless their parole conditions stipulate otherwise. Even then, the police officers are only required to inform the parole officers about the suspected infraction.
With this internal communication by the police, it looks like changes are coming thick and fast after the enactment of the recreational cannabis law in New York State.
While New Yorkers can now legally use cannabis recreationally, it has been permitted for medical use for several years now. As a matter of fact, many companies, both within and outside the United States, have taken steps to develop drug formulations from this plant. An example is British Columbia-based XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which is conducting pilot studies to establish the medical efficacy of three drug candidates made from combinations of cannabinoids such as CBD and THC.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the nation’s largest independent alkaline water company, has announced its latest partnership with CEFCO Convenience Stores, which will now offer Alkaline88’s single-serve products in more than 200 high-volume stores across six states. “Adding CEFCO as a customer is a big step in our continued convenience store expansion,” says Ricky Wright, president and CEO of The Alkaline Water Company. “Developing significant partnerships and adding key customers such as CEFCO will allow us to further grow our c-store footprint in addition to expanding distribution of our single-serve products. The continued C-store growth we are seeing is a testament to the strength of our brand and the trust and confidence that our loyal customers have in Alkaline88.”
Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
If you have been following the news lately, you may have noticed that the share prices of electric vehicle (“EV”) companies have taken a hit. However, this doesn’t mean that you should engage your parachute and bail out, as this price correction doesn’t necessarily mean the bull run of these stocks is over. Here are key reasons why the outlook is still bullish for EV stocks, according to a leading global wealth management firm.
The market share for EVs is increasing
Mark Haefele, a chief investments officer at UBS Global Wealth Management, points out that globally, sales of electric vehicles have been gaining steam. For example, the pandemic caused car sales to slump by 15% by the end of 2020, but that same year saw sales of EVs increases by 43%.
This increase gave EVs a 4.2% share of the global vehicle market, and this figure means that the EV sector can only climb higher and claim a larger share of the market.
For an investor, this means that the party isn’t over yet for the electric vehicle industry.
Vehicle electrification is still in its early stages
Never before has the automotive industry been faced by a disruption such as the current one which has seen governments around the world impose strict emissions controls as a way to slow down climate change.
Electric vehicles look set to take over the roads, and the strict timelines set by authorities in different jurisdictions to phase out traditional fuel-guzzling automobiles mean that the EV industry is just getting started. Price correction or no price correction, Haefele sees no reason for investors to alter their outlook for the EV industry.
For example, if Volkswagen plans to invest more than EUR 50 billion in electrifying its lineup of vehicles, there is no reason why any investor should think shares of EV makers won’t enjoy a good run for years to come.
The changes go beyond changing drivetrains
Haefele also points out that the changes taking place go beyond switching a diesel or petrol drivetrain for an electric one. In fact, several parallel innovations are taking shape as vehicle electrification is implemented.
An example is the development of autonomous driving coupled with the evolving preferences of younger drivers who aren’t interested in owning a vehicle. These two changes alone favor vehicle electrification as the cars of the future will be able to drive themselves to a pickup point indicated by a user.
The parallel changes, in effect, mean that vehicle electrification is almost certainly here to stay — a good sign for those interested in investing in this sector for the long term.
The options available to investors are likely to get even more exciting as they will have a wider pool to select from due to the entry of new players. For instance, global financial technology firm Net Element (NASDAQ: NETE) is awaiting the execution of a definitive agreement as well as shareholder approval before its planned reverse merger with fully electric vehicle maker Mullen Technologies Inc. is finalized. The new entity created will most likely be one to watch.
NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Kaival Brands (OTC: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets, has scheduled an investor call for Wednesday, April 14. Hosted by Kaival Brands CEO Niraj Patel, the call will kick off at 5 p.m. ET and will include a discussion of the company’s recent developments as well as a Q&A session. Interested parties are invited to submit pertinent questions by April 8 at investors@kaivablbrands.com. Interested individuals are also invited to participate on the call by dialing toll free 800-346-7359 in the United States and Canada, using the passcode 132056. A replay of the call will be available after the call concludes by dialing 800-332-6854, passcode 132056; that replay will be available for two weeks. “Our stockholders are part of the Kaival family, part of my family,” said Kaival Brands CEO Niraj Patel in the press release. “As our journey approaches a very significant milestone, I want to afford individual investors the opportunity to hear from me directly and answer questions they may have. I appreciate our stockholders’ trust in me and the company. I understand what they have at stake and my team and I take it very seriously.”
Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Our vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor. For more information, visit the company’s website at www.KaivalBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received conditional approval to offer its proprietary CBD products on Tmall, the world’s largest cross-border online marketplace. This news follows the company’s recent announcement that its Probulin Probiotics would also be available on Alibaba Group Holding’s Tmall Global (“Tmall”). The third most-visited website in the world, Tmall represents more than 750 million potential new consumers living across mainland China, Hong Kong, Macau and Taiwan. The announcement noted that the site provides unique opportunities for HempFusion to raise brand awareness and drive conversion through digital marketing campaigns, shoppable live streams, product demos and special offers. “Building on our established relationship with the Alibaba Group and Tmall, and introducing our premium HempFusion OTC Drug Listed Topical products throughout this premier Asian eCommerce platform, has been a major focus of our strategic expansion plan,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “We are now accessing one of the largest online consumer groups in the world with products formulated with approved drug monograph ingredients such as menthol for ailments such as pain. These products have already performed as best in class in select retailers in the United States, and we’re excited to see that follow through in the world’s largest market.”
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at http://ibn.fm/CBDHF
About ChineseWire
ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.
Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer
Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosed
A recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the evening
Brain cancer drug developer CNS Pharmaceuticals is also working on a solution to improve the quality of GBM care, seeing hope in its lead drug candidate, Berubicin, which showed promise in a small Phase 1 trial nearly 15 years ago
One patient from that Phase 1 trial was still alive and cancer-free as of the most recent assessment in November
CNS expects to begin a larger, multi-center potentially pivotal trial imminently (as well as collaborating on two Polish trials conducted by sublicensee partner WPD Pharmaceuticals), comparing Berubicin’s performance to the chemotherapy drug lomustine in hundreds of patients at nearly 60 oncology centers around the world
A new study recently completed by the Washington University School of Medicine in St. Louis has found that glioblastoma (“GBM”) brain cancer patients receiving the current chemotherapy standard of care had longer survivability rates if they switched from receiving treatments in the evening to receiving the treatments in the morning — encouraging news for patients with the incurable illness, as well as for neuro-oncology researchers attempting to develop improved treatments, including biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP).
“In my lab, we were studying daily rhythms in astrocytes, a cell type found in the healthy brain. We discovered some cellular events in healthy cells varied with time of day,” professor of biology Erik D. Herzog, PhD, stated in a Science Daily report on the study Herzog co-authored with professor of pediatrics and of neuroscience Joshua B. Rubin, MD, PhD (https://ibn.fm/TisXR).
“Working with Dr. Rubin, we asked if glioblastoma cells also have daily rhythms. And if so, does this make them more sensitive to treatment at certain times?” Herzog said. “Very few clinical trials consider time of day even though they target a biological process that varies with time of day and with a drug that is rapidly cleared from the body. We will need clinical trials to verify this effect, but evidence so far suggests that the standard-of-care treatment for glioblastoma over the past 20 years could be improved simply by asking patients to take the approved drug in the morning.”
GBM patients currently have an average 15-month survival rate after diagnosis of the illness. The Washington University study’s benefits were small — those who received the drug in the morning had an overall survival of about 17 months, while those who received it in the evening had an overall survival of about 13.5 months. But scientists hail any potentially significant increase in survivability as a step in the right direction for treating an incurable disease.
Furthermore, among a subset of patients with what are called MGMT methylated tumors, the study’s participants who took the drug in the morning averaged overall survival of about 25.5 months compared to 19.5 months — a difference of six months — for those who were medicated in the evening, the study’s authors reported.
CNS Pharmaceuticals is working to determine the efficacy of its lead drug candidate, Berubicin, in fighting off glioblastomas. In a small Phase 1 trial completed by another company well over a decade ago, 44 percent of patients saw their disease stabilize or improve. One Berubicin patient emerged cancer-free and as of the most recent medical assessment in November was still alive and still in remission nearly 15 years after the Phase 1 trial (https://ibn.fm/yZACY).
CNS now hopes to advance Berubicin to commercial production, with the start of its potentially pivotal clinical trial slated to begin this quarter. The global trial will compare Berubicin’s response to the effectiveness level of established chemotherapy drug lomustine in 243 GBM patients at about 35 clinical sites in the United States (https://ibn.fm/x8Zp2) and 25 more in foreign locations.
The company’s sublicensee partner, WPD Pharmaceuticals, will begin a similar Phase 2 clinical trial of Berubicin in Poland during the second quarter, with interim results anticipated by year’s end or early first quarter of 2022. WPD will also launch a Berubicin trial involving pediatric patients sometime later this year — the first significant investigation involving children with malignant gliomas (https://ibn.fm/CjWPj).
Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers. … However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able to cross the blood-brain barrier and achieve significant levels of activity in the brain,” CNS CEO John Climaco said in a webinar late last year (https://ibn.fm/d2OFK). “Berubicin may change that history because it is the first anthracycline that, based on limited clinical data, appears to cross the blood-brain barrier and achieve drug levels critical for efficacy against central nervous system malignancies.”
For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Wednesday, April 7th, 2021UncategorizedComments Off on $CNSP Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming Clinical Trial
Splash Beverage Group Inc. (SBEV) Leadership Team Brings Invaluable Expertise, Insight to Key Roles
Splash board members boast diverse, extensive leadership experiences in array of industries.
Board members have served for decades in key roles related to successful growth of Splash.
Splash Beverages operates in both alcoholic, nonalcoholic beverage segments.
The impact leaders have on organizations is almost impossible to measure — yet they are critical components of a company’s success. Splash Beverage Group (OTCQB: SBEV), a holding company of leading portfolio of beverage brands, blend of essential vitamins, minerals and electrolytes, is committed to building a leadership team — including stellar board members — with the expertise and insight necessary for the company’s growth in the trillion-dollar global beverage industry.
Most recently, Splash Beverage announced the appointment of Peter McDonough as an independent board member (https://ibn.fm/2EZXw). McDonough has an unparalleled C.V. for sitting on the board of an upstart company, and he brings incomparable marketing experience to Splash, the company noted, when making the announcement.
“We are lucky to be adding Peter to our board,” said Splash Beverage CEO Robert Nistico. “Over the course of his 30-year career, Peter has created successful marketing campaigns and built organizational capabilities that accelerated the growth of business enterprises ranging from small start-ups as well as multi-billion-dollar companies. Peter’s wealth of experience and insights gained while serving as Diageo’s North American president overseeing brand marketing and product development, as well as his vast professional network will be invaluable to Splash’s board of directors. His strategic insights offer helpful counsel as Splash accelerates the growth of our existing brands, TapouT Beverage and Salt Tequila, while adding new brands and expanding our distribution footprint into international markets.”
McDonough has garnered diverse and deep leadership experiences in industries such as personal care products, alcoholic beverages, consumer appliances, power tools and bioscience technology. He currently serves as CEO of Trait Biosciences and previously served in senior executive roles at Diageo, Procter & Gamble, Gillette, Duracell and Black & Decker.
At Diageo, McDonough acted as president as well as chief marketing & innovation officer. Under his expert guidance, the company launched more than 40 new products in less than a decade, resulting in more than $800 million in cumulative sales and the company’s consistent appearance in the industry’s annual (IRI/Nielsen) list of top-selling new products.
Other outstanding Splash Beverage board members include Nistico, who is a board member in addition to serving as Chairman & CEO; and Justin Yorke. Boasting almost three decades of experience in the beverage industry, Nistico was named Splash CEO and a member of the board of directors since inception. Prior to that, he served as Senior Vice President and general manager at Red Bull North America, where he was the fifth employee hired. Nistico was instrumental in building the Red Bull brand in North and Central America as well as the Caribbean. He’s also held key leadership positions at Diageo (formerly I.D.V./Heublein), Republic National (formerly the Julius Schepps Company) and the E&J Gallo Winery.
Yorke is a member of the board of directors and, in March of last year, was also named secretary for the company. With more than two decades of experience in finance — including almost half of that in Hong Kong — Yorke has managed funds for a private Swiss bank as well Peregrine Investments and Unifund, a high-net-worth family based in Switzerland. For the past ten years, Yorke has been a partner in San Gabriel Advisors and is the manager of the San Gabriel Fund, JMW Fund and Richland Fund.
Specializing in manufacturing, distributing, sales and marketing of various beverages across multiple channels, Splash Beverages operates in both the alcoholic and nonalcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and accelerate pre-existing brands to exit for cash events. The company’s management team has invaluable expertise and insight, and the company strives to identify brands it perceives to have highly visible preexisting brand awareness or pure category innovation.
Specifically, the company looks for brands and products that are on trend and deliver natural quality, health benefits, freshness and refreshment within their beverages. SBEV looks to maintain highest performance standards and focus on execution as it works with distributors and retail partners achieve and exceed all goals. In addition, the company offers support for members of the U.S. armed forces, first responders and health-care professionals.
NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
AmpliTech Group’s (NASDAQ: AMPG) Demand Backlog Increases; Company Stands at the Forefront of Emerging Technologies
AmpliTech Group, Inc. receives over $500,000 of orders from a major defense contractor and a leading satellite broadcaster
AMPG subsidiary, Specialty Microwave, received a $190,000 order from a leading broadcaster
AMPG also received a $366,000 order from a major defense contractor for the METIS Program
With increased demand, Amplitech’s backlog has now reached a record $2.2 million
AmpliTech Group (NASDAQ: AMPG, AMPGW), the provider of industry-leading SATCOM Low Noise Amplifier Solutions for the past 18 years, designs and develops top-quality microwave amplifiers using its experience, technical expertise, and superior design knowledge. AmpliTech announced that the company has received orders worth $500,000 from a major Fortune 100 defense contractor and a major satellite and cable TV broadcaster.
The company’s subsidiary, Specialty Microwave, acquired in 2019, is a satellite communications (SATCOM) products company. They received a $190,000 order from a leading broadcaster that will use Specialty Microwave’s unique equipment to process satellite ground station signals behind the antennas. Further, AMPG also received a $366,000 order for its premium low noise amplifiers from a major defense contractor in support of the METIS Program (https://ibn.fm/SMVJN).
Fawad Maqbool, the CEO and founder of Ampliteh Group, said that the company was very pleased to receive these orders that reflect the rapidly-increasing demand for high-performance products and its expansion into mainstream emerging technology applications. He went on to say that the demand has remained “pent-up” due to the COVID-19 pandemic, and that they expect bookings to increase in the 2nd half of the year.
With the growing demand for the company’s products, AMPG reached a record backlog this year. Amplitech announced that its backlog reached $2.2 million at the end of the Q1 of 2021. Fawad stated that the growing backlog indicates the increasing demand and revenues in the upcoming quarters.
To meet the skyrocketing demands, the company is geared towards strengthening its management team and resources as outlined in the S-1 filing and the recent $11 million capital raise by AMPG. Amplitech is well-positioned and equipped with the necessary funds to expand the company’s disruptive technology base, generate increased revenues, and capture greater volumes of its target technology market sectors (https://ibn.fm/liGen).
The company’s products cover a frequency range from 50 kHz to 44 GHz, with plans to eventually offer designs up to 100 GHz. AmpliTech also has developed new products for the 5G/6G wireless ecosystem and infrastructure.
NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at https://ibn.fm/AMPG
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
NetworkNewsWire Editorial Coverage: Despite COVID-19’s impact on galleries, auction houses and retailers, the global art market circulated more than $50 billion in art, while other collectibles such as coins and trading cards saw record sales. Amazingly, an estimated 10% of art is stolen annually, and an estimated 50% of all sports memorabilia is estimated to be fake per the FBI. To get a flavor of just how difficult it is to know if something is stolen and replaced with a near-perfect forgery, Interpol’s stolen artwork database has more than 50,000 items across 134 countries listed in it. Experts note that scams and hacks are already hitting the exploding market of digital collectables known as NFT’s (non-fungible tokens). Taking the collectables world by storm, a non-fungible token is a unit of data on a blockchain ledger that represents a unique underlying asset. As with most other things, crooks flock to where the money is, and right now NFT’s provide plenty of money and new vulnerabilities. That’s exactly why FACT Inc. (OTC: FCTI)(Profile), a recognized global leader of fine art and collectible authentication technology, has recently expanded into the burgeoning NFT market. Shares of companies with interest in or association with NFT’s have enjoyed a nice advance lately, including CurrencyWorks Inc. (OTC: CWRK), Takung Art Co. Ltd. (NYSE American: TKAT), Oriental Culture Holding LTD (NASDAQ: OCG) and Jiayin Group Inc. (NASDAQ: JFIN), as investors seek exposure to the popular technology in the collectables market.
NFT’s are one of the hottest market segments today, with the combined market cap of major NFT projects increasing by 1,785% in 2021.
FACT Inc. uses forensic technology to authenticate and analyze fine art and collectibles capturing unique hashes from the forensic data.
FCTI is expanding into the NFT markets, using its suite of proprietary technologies to become the first company effectively linking NFT’s with physical assets.
The company secures its highly customizable data packages for clients with blockchain technology.
NFT’s Explode onto Wall Street
NFT’s are digital tokens that prove the authenticity and ownership of a digital asset. An NFT is a unique file stored on a blockchain that certifies ownership of the digital asset and direct representation of the underlying asset and its value.
The “non-fungible” in NFT simply means that the token is unique and can’t be replaced with something else. To lend some clarity through a physical example: a dollar bill is fungible. It can be swapped with another dollar bill and have the same function and value. A 1952 Topps Mickey Mantle rookie baseball card, the world’s most expensive baseball card, which sold for $5.2 million in January, is non-fungible because there isn’t another card identical to it. The same goes for a Monet painting, only it couldn’t be directly linked to an NFT because it is a physical asset — that is until now.
An NFT can be anything digital: a song, a video, a GIF or even a tweet. Sports videos are spiking in value, including an NFT of a video clip of a Lebron James dunk recently selling for over $200,000. The white-hot commodity today is art, as evidenced by Mike Winkelman, a digital artist known as Beeple, selling his JPEG titled, “Everydays — The First 5000 Days” at a Christie’s online auction for a stunning $69.3 million, including fees. Just as with any great piece of artwork or cultural property, replicas or copies can be made for distribution, but NFT’s are the one-of-a-kind original.
With worldwide reach, FACT Inc. (OTC: FCTI)is revolutionizing security for the art and collectibles market. Using forensic technology presently used by global law enforcement agencies for ballistics, FACT provides products and services to authenticate and analyze fine art and collectibles. FACT offers an eponymous turnkey suite of products, called FACT, an acronym for Forensic Asset Certification Technology, for comprehensive data collection and tracking to ensure the authenticity of any item.
The software application uses blockchain, an immutable digital ledger, to store all pertinent information including authentication, condition reporting, GPS tracking and provenance data, that is available in real-time to the appropriate parties. The FACT software application is applicable to an array of customers within the fine art and collectible industry including secured lending, insurance, dealers, artists, auction houses, grading companies, and private collectors. None too soon, servicing the NFT market has been added to the FACT portfolio of offerings.
White Collar Crime Meet Next-Gen Protection
Adapted from the ballistics industry, FACT uses forensic technology and applies it to the art authentication industry. More specifically, the company has developed cutting-edge technology using noncontact, nondestructive white light interferometry, an optical method for surface height measurement to generate three-dimensional scans capturing more than 100,000 images at a resolution of two microns, a level impossible to forge. The technology is so precise that it can detect nuances such as a paint brushstroke in a forgery leaving a thicker line of paint than an original, a detail that could never be noticed even by the most trained eye.
Once a scan of a collectable is recorded, FACT isn’t done by any stretch. If a valuable is to be transported, it is scanned again using FACT analytic software to verify the authenticity, tracked using GPS technology while in transit and scanned again once it arrives at its destination. All scans are recorded and stored, maintaining a constant record of condition (or changes in) and providing a library of scans for future comparisons.
First Mover: FACT’s Physical Asset NFT’s
With flagship operations well established, FACT is now bringing its expertise to the burgeoning NFT market, a market that has thus far been limited to digital assets. FACT’s forensic technology creates the important tamper-proof link needed to tokenize a physical asset to an NFT. In other words, just as Beeple’s $69-million digital image was permanently affixed to a digital token, FACT will be able to do this with a framed Picasso hanging on a wall by creating a scan using its proprietary imaging technology, a first for the industry.
The strategy is bigger than just being the first to connect physical assets with an NFT. FCTI management says it plans to not only offer NFT’s as a service to FACT clients but also to partner with a platform to offer a seamless trading process to clients. If indeed some pundits are correct that NFT’s will be the preeminent way to buy, sell and collect digital art, FACT is making the right move with its authentication technology combined with in-house auctions. Christie’s, a 255-year-old auction house branching out into the space for the Beeple auction, certainly lends credibility to the future of the market. FCTI is positioned to bring the unique transactional benefits of NFT’s to transacting physical assets changing the way buyers and sellers interact in the market forever.
The Blockchain Architecture
The totality of the existing FACT platform architecture dovetails perfectly with this expansion into NFT’s. The company’s system provides a secure home for all the requisite provenance records, database of scans, etc., neatly packaged and protected on the FACT blockchain. These records store all necessary documentation for seamless creation of NFT’s of a tangible object or a digital recreation of the object with user-specified smart contracts for near instantaneous execution of transactions between buyers and sellers.
Securing the documentation on the blockchain is part-and-parcel to an NFT. Each NFT is customized to a client’s specifications and can feature any number of complex mechanics. Usage analytics, royalties, value enhancements, restricted specified displays, capped supply and usage restrictions are only a few of the customizable options that can only be confidently protected through blockchain architecture such as that built into the FACT system.
Polishing the Edges
NFT’s are a bit reminiscent of Bitcoin a number of years ago. Traders are jumping into the space simply because of the buzz word, most likely with little understanding of what they actually even are. That has provided a boon to a number of stocks as the trend is only now getting underway. Fact is, much like Bitcoin, people will be educated on NFT’s gradually because it is a market squarely facing the younger generations that are deeply rooted in a digital world.
CurrencyWorks Inc. (OTC: CWRK), formerly known as ICOx Innovations, has been a pioneer in the blockchain and digital rights protection for years. The company was instrumental in the development of Kodak’s first digital tokens for protecting its customers digital photo property. The Los Angeles-based company operates its CurrencyWorks Collectibles NFT platform, is working to create the first NFT for the Barrett-Jackson Auction Company and recently partnered with XTM Inc. regarding a NFT payment platform scheduled to launch this quarter.
Takung Art Co. Ltd. (NYSE American: TKAT), a Hong Kong-based company, operates an online trading platform for art collectors and investors to acquire shared ownership in Asian and other fine art. Takung generates revenue via services from its online electronic platform and is experiencing improving financials underscored by a healthy art and collectable market in Asia.
Oriental Culture Holding LTD (NASDAQ: OCG) is another that has felt tremendous volatility in its stocks owing to a connection to NFT’s. The company, through its Hong Kong subsidiaries, provides online collectibles and artwork e-commerce services, which allow collectors, artists, art dealers and owners to access a much bigger art trading market where they can engage with a wider range of collectibles or artwork investors.
Jiayin Group Inc. (NASDAQ: JFIN), a Chinese online individual finance marketplace, is in the same boat as TKAT and OCG insomuch that its stock has made moves in both directions because investors may be betting it is expanding into the NFT business. The crux of the conjecture is that the company has the infrastructure to facilitate transparent and fast connections between investors and borrowers, a business model that aligns with deals in the NFT markets.
According to Forbes, the combined market cap of major NFT projects has increased by 1,785% in 2021, not even a full three months into the year. New NFT’s are hitting the market every single day with no signs that the craze is going to slow in the near future.
For more information about FACT Inc., please visit FACT Inc.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Wednesday, April 7th, 2021UncategorizedComments Off on $FCTI NFT’s and Revolutionizing Security in the Art and Collectibles Market
According to analysts from Jefferies, two decades from now, there may be no smokers in the market. Tobacco firms and governments happen to be on the same side in this shift, especially now that more countries are adopting smoke-free targets and companies are advocating for smokers to use alternative products such as oral nicotine and vaping.
In a note, one of the analysts, Owen Bennett, stated that as tobacco ambitions and regulators align, no smokers in a generation may become a reality, adding that the only way to achieve this would be through RRP support.
Analysts aren’t the only ones having this opinion. Citigroup Inc., which is also of the opinion that cigarettes may become obsolete, expects that by the year 2050, smoking will have disappeared from various parts of Latin America, Australia, some parts in Europe and the United States, if the declining trend that has been observed in the recent years continues.
A statement by Citigroup Inc. analyst Adam Spielman notes that in the last five decades, there has been a decline in smoking due to what is known as the ESG Squeeze, or taxation, regulation and pressures from societal attitudes.
Since the beginning of 2020, the MSCI World Tobacco Index has performed well below the expectation of the wider MSCI World Index, as Imperial Brands Plc lags behind and Swedish Match AB, which manufactures smokeless tobacco products, performs better.
Bennett noted that in the shift to smoke free, Imperial Brands would struggle due to the company’s overreliance on legacy assets in the United States and Europe. He then proceeded to downgrade his rating on the company’s stock from buy to hold.
On the other hand, Bennett stated that well-placed firms included Philip Morris International Inc., which is a manufacturer and seller of tobacco, cigarettes and products that contain nicotine and dominates the market, and British American Tobacco Plc, which recently ventured into marijuana. He then proceeded to upgrade his recommendations on Altria Group Inc. and BAT from hold to buy.
He asserted that if the introduction of RRP did bring about an end to smoking, growth should be just as good, especially if big tobacco is still getting its fair share, if it wasn’t better than the past.
As the number of smokers goes down as predicted by analysts, the effects of infectious diseases such as COVID-19 on patients are likely to be less severe since smoking weakens the lungs and the coronavirus can deliver a death blow once it encounters such weakened lungs, especially when the infection isn’t detected early. Fortunately, XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) successfully validated a rapid and accurate PCR COVID-19 test device that will dramatically reduce the time it takes for one to get results after samples are taken.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
If you’re looking for penny stocks to buy right now, you’re not alone. The stock market as a whole is trading higher this week, thanks to economic data on Friday. Though the market was closed, that didn’t prevent the weekly jobs figures from coming out & they were strong.
Nonfarm payrolls increased by 916,000 in March, and the unemployment rate declined to 6%. Dow Jones had estimated 675,000 for the figure. Another 156,000 jobs were added to the totals for January and February, thanks to revisions. All of this has translated into a strong premarket session to kick-off the post-holiday week.
Traders Look To Analysts For Confirmation
Clearly, thanks to the strong numbers (or maybe the lower expectations), the market reaction has boosted shares across most sectors so far. Traders will look to analysts for consensus on things like economic data and even forecasts for individual stocks. In cases where expectations are high, you’ll usually see some favorable momentum in the market. The opposite can be true when forecasts are a bit bleaker.
But here’s the question, do analyst ratings matter when it comes to finding penny stocks to buy ? In my opinion, there is something to be said about it. While it isn’t the only thing you should look for when researching, it can be a placeholder. For an analyst to follow such a small company, there must be at least a few things that appeal.
It might be a treatment pipeline, or it could be a pending commercial launch for a product. Whatever the case, not all penny stocks are attractive enough that analysts will jump on board.
Hot Penny Stocks To Buy According To Analysts
If you’re looking for analyst-rated penny stocks with Buy ratings, there are plenty to choose from. Keep in mind that most companies that fit the definition of a penny stock (shares traded under $5) are early-stage companies. They need to raise money, their business models can change, & the prices of the stocks themselves can open highly volatile scenarios in the market. But if you’re ok with a little risk and like to follow analysts, here are a few hot names gaining interest in April:
Penny Stocks to Buy [According To H.C. Wainwright]: Uranium Energy Corp. (NYSE: UEC)
Rating: Buy
Price Target: $5
Uranium Energy Corp. has been in the spotlight this year thanks to growing interest in alternative energy. As the name suggests, Uranium Energy focuses on uranium mining and exploration. Last month was an active one for the company with new uranium purchases in the US.
The company reported 800,000 pounds were secured. Including the previously announced acquisition of 400,000 pounds, the company also entered into contracts to purchase a total of 1,200,000 pounds of U3O8 at a volume-weighted average price of $28.94 per pound.
To help with this initiative, the company has begun raising additional funds. As of the end of last month, it had secured a deal to raise over $30 million from institutional investors, which equated to 10 million shares at $3.05 per share.
Considering that UEC stock was trading below $3 for most of March, this was seen as a solid deal for the company. So much so that analysts at H.C. Wainwright adjusted their price target from $3.60 to $5. The firm also has a Buy rating on the stock. Based on Thursday’s closing price, this forecast is over 50% higher than the current market price.
Penny Stocks to Buy [According To Canaccord Geuity]: Sesen Bio Inc. (NASDAQ: SESN)
Rating: Buy
Price Target: $7
Analysts have also grown bullish on Sesen Bio Inc. Canaccord Genuity recently boosted their price target on the stock from $5 to $7. Jefferies had also followed suit, upping its target from $3 to $6. Both also have a Buy rating on Sesen Bio.
One of the main points of interest has been on the company’s pipeline. In particular, its Vicineum is being studied for non-muscle invasive bladder cancer. Last month, Sesen submitted its Marketing Authorization Application to the European Medicines Agency under its centralized procedure.
What’s more, the company and Qilu Pharmaceutical announced an approved Investigational New Drug Application in China for Vicineum. Qilu Pharmaceutical is the company’s partner in China and can now conduct clinical trials to assess the efficacy and safety of Vicineum as a potential treatment. It expects to file a product market application for the drug in 2022, according to Sesen.
Penny Stocks to Buy [According To Needham]: Mereo BioPharma Group (NASDAQ: MREO)
Rating: Buy
Price Target: $10
Shares of Mereo BioPharma gained momentum early on Monday thanks to new analyst coverage from Needham. The firm started MREO stock with a Buy and gave an initial price target of 10, which is 195% higher than last week’s closing price.
The clinical-stage company has targeted oncology and rare disease with a pipeline of treatment candidates. Late last month, Mereo gave a business update outlining several key initiatives that the market could look for heading into 2021.
Dr. Denise Scots-Knight, Chief Executive Officer of Mereo explained, “We were able to further strengthen our partnering portfolio with licensing agreements for setrusumab and navicixizumab, with significant milestone payments tied to each deal. Our internal pipeline has continued to progress with etigilimab currently in a Phase 1b/2 basket study and alvelestat in a Phase 2 POC study for patients with AATD as well as a Phase 1 study in patients with COVID-19…As we look toward 2021, I believe that the Company is well-positioned to deliver on multiple milestones.”
It’s also worth mentioning that the company recently raised funds to put toward its clinical programs. Next week, the company will be at the Needham Healthcare Conference, April 12-15, 2021. So if MREO is on your list of penny stocks to watch, keep these dates in mind.
Will Analysts Be Right About These Penny Stocks?
Just like any investment, nothing is a guarantee. If any of these are on your list of penny stocks right now, don’t forget about your risk/reward outlook. If analysts say that some stocks are a “sell,” but the companies have big momentum thanks to new developments, then analysts may have been a little off in their rating. At the same time, if analysts say “buy” and the company announces a huge earnings miss and change of operations, then the same holds true with this example as well.
The one thing that matters is making money with penny stocks. So if you’re using analyst ratings, take them into account but do more research to arrive at a well-thought-out conclusion as to whether they’re good penny stocks to buy or if they should be avoided for now.
Monday, April 5th, 2021UncategorizedComments Off on $UEC Hot Penny To Buy According To Analysts With Price Targets Up To 195%
TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Offering Legal-Aged Smokers a Better Alternative
TAAT is building Beyond Tobacco(TM), a nicotine-free and tobacco-free smoking experience, into iconic American brand
In 2019 sales for legal global tobacco market reached approximately $818 billion, with largest category being combustible cigarettes
TAAT has created alternative that incorporates all five sensory elements of smoking without harmful side effects
TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) has created a nicotine-free and tobacco-free smoking experience that has been launched in Ohio to resounding success. And no wonder. The company is dedicated to providing legal-aged smokers the option of keeping the smoking experience they love but without the harmful side effects of nicotine and tobacco.
TAAT has an aggressive marketing strategy to persuade current tobacco smokers of legal age to abandon tobacco cigarettes in favor of an alternative option. The objective is to build Beyond Tobacco(TM), a tobacco-free and nicotine-free alternative offered in a combustible “stick” format, into an iconic American brand.
In 2019 sales for the legal global tobacco market reached approximately $818 billion, with the largest category being combustible cigarettes (https://ibn.fm/uflC9). Consumers need suitable alternatives that provide a similar experience without the harmful effects of nicotine and tobacco.
Health and wellness saw some strong trends in 2020 during the pandemic, including an active appetite for immunity-boosting products, plant-based foods and mental health awareness (https://ibn.fm/DrUjg). These industries provided quality alternatives and awareness around poor coping techniques at just the right moment.
The tobacco and nicotine industry continues because of its addictive qualities, regardless of the growing awareness and multiple products that claim a path toward cessation. The problem is that the experience of smoking is pleasurable. It is a coping mechanism when stressed, a habitual reaction, and is usually coupled with behavioral rituals (https://ibn.fm/kidop). Beyond the nicotine and tobacco, the physical act of smoking can be a pleasurable experience that is missed.
The Beyond Tobacco patent-pending base material of TAAT allows the smoker to continue the experience, the coping mechanism and the habitual behavior without the harmful side effects of tobacco and nicotine. What differentiates Beyond Tobacco from other alternative options is that the experience it creates is fundamentally no different from smoking a regular tobacco cigarette — with crucial difference: there is no tobacco.
A 14-step process is used to ensure that Beyond Tobacco tastes, smells and smokes just like tobacco but contains no tobacco. All five important sensory elements involved when smoking a tobacco cigarette are involved when smoking a TAAT. This includes the packaging and smoke volume, the crackling when lit, the tobacco-like scent and the hand-to-mouth motor habits. Even the ashes are similar to tobacco ashes and can be “flicked” from the combustible stick.
Another added bonus to TAAT as an alternative is the price point, a 43% savings from a pack of Marlboro. Appealing to the pocketbook just one more way to encourage legal-aged smokers to reach for the TAAT alternative and start moving forward into a nicotine and tobacco-free lifestyle.
For more information, visit the company’s website at www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, was featured in a recent article published by The Wall Street Journal. The piece, titled, “CFOs Zero in on Shareholders as Stock Volatility Soars,” covered last quarter’s extreme stock-price moves followed by resurfacing of the age-old question for company executives as to whether they have the ability to exert any influence over their company’s share price. Delving into what some executives are doing, the article points to limited options based on what these executives don’t know, “including who holds certain shares, as well as the dominance of passive investing.” “Companies also try balancing the shareholder base over time by attracting certain types of new investors to their stock. They usually start with finding out more about their current shareholders. Investment banks and other financial-services firms can provide weekly or monthly reports about large institutional shareholders, trading volumes, the amount of stock that is being shorted and other information,” the article reads. “Technology company SRAX Inc. has a platform that can give granular information about shareholders, including those that have specifically asked to be hidden, said SRAX Chief Executive Christopher Miglino. ‘Our sales have increased significantly over the past two quarters,’ he said, attributing it to companies eager to know more about who owns their stock.”
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and www.MySequire.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Current POAI Chairman J. Melville (“Mel”) Engle has been appointed to CEO position
Engle has held executive positions throughout his career at leading pharma and medical device companies, including Dey L.P. (a subsidiary of Merck KGaA), Allergan, Anika Therapeutics and Thermogenesis
During his time at Merck’s Dey L.P., Engle transitioned the company from generics to branded products and grew sales from $250 million to $600 million
The world today uses big data for all sorts of predictions, especially consumer behavior. One day, though, big data and technology could prove even more valuable as the catalyst to flip the healthcare script from one that is almost exclusively reactive, to a proactive one that foretells disease at best and eliminates trial and error in therapy decisions after a disease presents at worst. That’s the hope of Predictive Oncology (NASDAQ: POAI), a company using an extensive dataset collected over the last 15 years to better inform individualized cancer therapies today as it advances development of its predictive tumor profiling technology rooted in its artificial intelligence (“AI”) platform.
The company recently named J. Melville (“Mel”) Engle as chief executive officer. Engle has been a director at POAI since October 2016 and has sat as chairman of the board since January 2020. He will take on the top executive role and continue to serve as the company’s chairman.
Engle has a history of success on multiple verticals in business development and a proven track record during more than 20 years holding C-level positions at healthcare and biotechnology companies. His skillset is particularly impressive with regards to properly positioning a company, launching products and expanding sales.
That experience will be invaluable as CEO of Predictive Oncology, which operates through three primary subsidiaries, two of which are in the revenue stage. The company’s Helomics division is an area of focus as it targets researchers in pharmaceutical/diagnostic companies to provide cancer treatment recommendations– the market segment where there is unmet need and pharmas have money to spend to improve patient care.
For the last decade-and-a-half, the company, through its subsidiaries, has been collecting a trove of more than 150,000 physical models of tumors and generating data valuable to clinicians. Growing revenue from this portion of the business strategy is integral to funding the requisite clinical research that will validate the AI model in the future.
Prior to starting his consulting practice in 2012, Engle was CEO of NASDAQ-listed Thermogenesis. Thermogenesis designed, developed and sold medical devices that enabled the practice of regenerative medicine.
In 2002, Engle was recruited by Merck KGaA to serve as president and CEO of Dey L.P, a division of Merck. Dey L.P., a pharmaceutical company focused on the development and commercialization of products for respiratory, allergy and other breathing disorders. Under his leadership, Dey was transformed form one selling 90% commodity generics to one selling 90% branded products, during which sales surged from $250 million annually to over $600 million.
Engle was also regional director, North America for Merck’s Generics Group, where he led all their North American businesses, including Dey, Genpharm, Inc. (Canada) and Genpharm, L.P. (U.S.) with total sales of $800 million and 1,200 employees. That role was subsequent to spending 14 years as a senior executive (CFO, managing director (Canada), senior vice president (Latin America/Canada), and senior vice president (U.S. Sales) with Allergan.
“I believe Predictive Oncology is positioned for success and I look forward to working with our team to achieve its strategic short- and long-term objectives. I am excited about the prospects of making a positive impact in enhancing the value for our stakeholders,” said Mr. Engle in a press release announcing his new CEO position (https://ibn.fm/7v4eB).
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced that the Canadian Food Inspection Agency (“CFIA”) has granted PlantX with a license to import packaged plant-based products from the United States to Canada (the “Import License”). According to the update, the operational milestone champions PlantX as a principal one-stop shop for everything plant based and advances the company’s plant-based movement by distributing U.S.-manufactured plant-based products to the Canadian marketplace. The Import License complements PlantX’s success in creating a diverse infrastructure of partnerships with plant-based vendors across the United States. With the license, the company seeks to make the most of its partnerships to increase awareness of the plant-based lifestyle by providing access to a greater selection vegan and vegetarian food choices throughout Canada. “We are extremely pleased to be at the forefront of bringing U.S.-manufactured plant-based goods to Canada,” said Julia Frank, PlantX CEO. “The new license marks a crucial step in our expansion as leaders in the plant-based space, by ensuring that we can be first to market in Canada with plant-based brands originating in the USA.”
In addition, a new episode of the PlantX vodcast show will be available today at 8 PM ET. To watch the vodcast, visit https://ibn.fm/F34B5
As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.
NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Mohawk Group (NASDAQ: MWK), a third-party seller to Amazon, is set to capitalize on the e-commerce opportunities brought by Amazon through its significant market share. “As per a report published by Similarweb, Amazon has estimated traffic of 2.5 billion monthly visitors, capturing nearly 1/3 of the online market share,” reads an article discussing this. “As a third-party seller to Amazon, Mohawk is set to leverage e-commerce opportunities through the giant online platform.” MWK also has proprietary technologies, among them the AI Mohawk E-commerce Engine (“AIMEE”), to help it take full advantage of these opportunities. “Mohawk conducts market research through the AIMEE platform and analyzes the data to discover market opportunities for new and existing products. AIMEE provides advanced financial modules and dashboards to track financial projections and live commerce from a central platform. Further, using AI-powered chatbots, AIMEE automatically follows up with customers for the satisfaction of their purchase.”
Mohawk Group is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has 12 owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high-caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information about the company, visit www.ir.MohawkGP.com.
NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at http://ibn.fm/MWK
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, today announced the appointment of Kristen Helsel as the company’s chief revenue officer. Helsel will be instrumental in driving the company’s hyper-growth, performance, strategy, and alignment of the organization’s revenue-generating departments. “Kristen has a proven track record for growing revenues in both the automotive and energy management industries, as well as building and leading high-performing sales teams,” said Ideanomics CEO, Alf Poor. “We are excited to bring someone on board with experience at the intersection between automotive and energy that is essential to successful EV adoption. Kristen joins Ideanomics at an important time when we are poised for growth in all of our markets.”
Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. The company’s Ideanomics Mobility division is a service provider that facilitates the adoption of electric vehicles by commercial fleet operators through offering vehicle procurement, finance and leasing, and energy management solutions under its innovative sales to financing to charging (“S2F2C”) business model. Ideanomics Capital is focused on disruptive fintech solutions for the financial services industry. Together, Ideanomics Mobility and Ideanomics Capital provide global customers and partners with leading technologies and services designed to improve transparency, efficiency and accountability, and the company’s shareholders with the opportunity to participate in high-potential, growth industries. Ideanomics is headquartered in New York, NY, with offices in Beijing, Hangzhou and Qingdao and operations in the U.S., China, Ukraine, and Malaysia. For more information, visit www.Ideanomics.com.
NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at http://ibn.fm/IDEX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has released both an operational update and the filing of its annual and fourth-quarter financial results for the fiscal year ended December 31, 2020. Company highlights include being ranked no. 2 in Brightfield Group’s most recent survey in the CBD Brand Awareness (U.S.) category, as well as SPINS naming its proprietary Probulin Probiotics product fastest-growing probiotic brand in 2020 out of the top 10 in the country. Other highlights included being the no. 2 CBD holding in AdvisorShares Pure US Cannabis ETF, being one of only a few companies to offer OTC drug-listed topical products, and having its OTC Tropical products ranked top in both sales dollars and units sold at a major U.S. food & drug mass retailer. In addition, HempFusion completed a digital relaunch, which increased online traffic by 10 times; completed a $17,000,000 initial public offering (“IPO”); commenced trading on the Toronto Stock Exchange, becoming the first U.S.-based CBD & wellness products company to list directly on the TSX; and launched the Probulin store on Amazon. “COVID and continued lack of clarity from the FDA related to official regulatory guidance for CBD used in dietary supplements, foods, and beverages has made 2020 a challenging year,” the company reported in the press release. “However, these challenges have led to strategic changes, establishing the foundation for HempFusion to succeed in 2021 and beyond. There are no quick and easy ways to navigate this dynamic and emerging industry. The company remains focused and highly optimistic that the five-channel strategy and international expansion will drive significant success throughout 2021 and beyond.”
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at http://cnw.fm/CBDHF
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
Senator Tina Smith of Minnesota is calling for the Biden administration to resume a study that could possibly affect the proposed Twin Metals Mine. Last week, the senator sent a letter to Interior Secretary Deb Haaland and Agriculture Secretary Tom Vilsack, asking them to continue with a study on the safety of mining copper-nickel-sulfide ore in the Rainy River Watershed, which includes the site of the proposed Twin Metals Mine as well as the Boundary Waters Canoe Area Wilderness and Voyageurs National Park (BWCAW).
The study was commenced under the Obama administration but terminated under the Trump administration. It would not affect the planned PolyMet mine or iron ore mining, which are located in another watershed.
In the letter, Smith stated that mining was an important tradition in the northeastern parts of Minnesota, a tradion that was a source of employment; the letter also acknowledged BWCAW is an irreplaceable and fragile source. The senator noted that the decisionmaking process concerning the proposed withdrawal must be unbiased, complete and through.
Smith stated that the study process, which commenced back in 2017, was to have taken two years, adding that it would now be accomplished in less time if it was restarted because it had already begun.
The letter got a swift response from supporters of copper mining, which include two Republican state lawmakers who referred to the letter as anti-mining.
In a news release, the chair of the Senate Mining and Forestry Committee, Sen. Justin Eichorn, stated that the mines found in north Minnesota already went through some of the strictest environmental regulatory standards in the world, which is why he was against adding another layer of red rape for political purposes. In another news release, Rep. Spencer Igo claimed that the senator was playing politics with the jobs and families in the region, despite her noting that mining was an important tradition in the state.
Also in response to Smith’s letter was Twin Metals’ statement, which asserted that its proposed mine was already undergoing environmental reviews, both at the federal and state levels. The company pointed to an Environmental Impact Statement that had been issued in 2012 by the U.S. Forest Service stated that any additional possible effects should be evaluated as part of a specific mining proposal.
In its news release, Twin Metals stated that requiring a nonspecific and additional study be conducted when there already exists a data-informed and detailed proposal in place for the company’s mine not only undermined the regulatory system but also trust in science. Twin Metals plans to employ more than 750 individuals if the mine is constructed.
When the Rainy River Watershed copper mining project finally kicks off, the company undertaking the project is likely to create value for its shareholders in a manner akin to what Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) is doing through its pursuit of gold and silver.
NOTE TO INVESTORS: The latest news and updates relating to Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) are available in the company’s newsroom at https://ibn.fm/EXN
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
Global Metals & Mining Investor Conference Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
PR Newswire
NEW YORK , April 5, 2021 — Virtual Investor Conferences, the leading proprietary investor conference series today announced that the presentations from the March Extractive Industry lnvestor Conference are now available for on-demand viewing.
The company presentations will be available 24/7 for 90 days. Investors, advisors and analysts may download shareholder materials from the “virtual trade booth” for the next three weeks.
Participating Companies:
Presentation
Ticker(s)
Keynote Presentation: By-Passing China in the Economic Recovery
To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences ® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
Monday, April 5th, 2021UncategorizedComments Off on $UUUU Global Metals & Mining Investor Conference Presentations Now Available for On-Demand Viewing
Researchers struggle to understand the immediate effects of COVID, with no clear census on the long-term neurological impact
COVID-19 has shown itself to be unique in how it interacts with the brain
Brain e-tattoos implanted in forehead will be next wave of innovation for neurology
Brain Scientific (OTCQB: BRSF) is meeting the growing need for improved brain monitoring with cost-efficient, disposable, and portable cutting-edge technology. This last year has seen an increased demand for disposable neurological technology accessible to all, adaptable for widespread use, and that provides quick, reliable information on the patient’s condition.
As the pandemic winds down, thanks to dedicated medical workers, social-distancing, mask-wearing and new vaccines, there are still many questions that need to be addressed.
The scientific world is only at the beginning of truly understanding the effects of COVID-19 on the brain. A year into the pandemic, researchers struggle to understand the immediate effects, with no clear census on the long-term impact. Neurological symptoms may go well beyond a loss of taste and smell or “brain fog” to problems with attention, concentration, and multitasking. The question is, how long will these symptoms last, and will patients eventually recover.
The Global Council on Brain Health (“GCBH”) has stated that critical research is needed in assessing how COVID-19 impacts later-in-life cognitive decline or dementia. It is not just the virus that needs to be studied, but also the impact of isolation during the pandemic on older adult brains.
COVID-19 has shown itself to be unique in how it interacts with the brain. Megakaryocytes, cells that produce platelets and primarily reside in bone marrow, have been found in the autopsied brains of COVID victims. This phenomenon has never been seen before. It may block blood flow to the brain and thereby be responsible for brain fog.
Figuring out why some patients are unaffected cognitively from COVID while others are left with significant and possibly long-term effects is essential in understanding this virus. More monitoring is needed to find the answers. That’s where Brain Scientific’s cutting-edge technology comes into play.
The NeuroEEG(TM) device is a portable, wireless, and compact device that acquires, records, transmits, and displays the wearer’s electrical brain activity. This device works in conjunction with the NeuroCap(TM), a hospital-grade disposable EEG headset featuring 19 active channels and 22 electrodes that comes in sizes for adults and pediatric patients. These devices are portable, making it simpler to take the needed tech to the patient rather than bringing the patient to the equipment.
The company is working on development of Brain E-Tattoo(TM) that in the future will provide access to long-term studies and inroads in helping identify root neurological problems. This tiny device will use graphene-based electrodes connected to the micro EEG clipped behind the ear that then transfers data to a cloud application. The data will be continuously analysed by artificial intelligence, which provides 24/7 uninterrupted monitoring.
“COVID-19 put a spotlight on the outdated and inefficient EEG testing protocols,” said Boris Goldstein, BRSF co-founder and executive. “Disposable technology made a significant impact to ensure brain scans could occur safely during the pandemic. Now, brain e-tattoos implanted in the forehead will be the next wave of innovation for neurology. The advancement will allow for long-term monitoring capabilities and uninterrupted data collection from patients with neurological conditions. Clinicians will be able to identify brain wave activity beyond the clinical setting with no impact to the patient’s daily life.”
Thanks to cutting-edge technology such as BRSF’s NeuroCap, NeuroEEG and e-Tattoo, the answers may just lie right around the corner.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Launches Live Holoportation Feature in its AiR Show Mobile Application
Nextech AR Solutions Corp. recently launched the live holoportation feature in its AiR Show app
During the launch, Nextech CEO, Evan Gappelberg, provided a live demonstration of the holoportation technology, through which viewers could beam his hologram into their homes
Nextech purchased the AiR Show app from TRICK 3D, and since then, it has rolled out improvements that now make it ideal for use in multiple industries
In a statement released back in February as Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) launched AiR Show version 2.0 – an app that turns people into holograms that users can then interact with or listen to – Nextech’s Director of Interactive Experience, Elliott Rothman, noted that the company had several improvements in the pipeline (https://ibn.fm/E1Qvg). Thus, with the launch of the LIVE holoportation technology on the mobile app on March 26, Nextech made good on its promise to keep revamping the platform. The launch featured a live demonstration that enabled viewers to beam the hologram of Nextech CEO Evan Gappelberg into their homes.
Speaking in an interview with Steve Darling from Proactive (https://ibn.fm/I4xCi) that aired shortly after the launch, Evan went into great detail to explain what the app will achieve through the new holoportation technology. He described holoportation as the transportation of a product or person from a particular location, for example, a home or warehouse, virtually, all around the world.
Evan also noted that the live holoportation demonstration did not require any sophisticated technology to bring it to fruition and could, in fact, be done from anywhere. “In this case, it was my home,” he explained, “which shows you how little equipment you need. You didn’t need to be in a studio. There were no crazy cameras. It was literally my iPhone 12 Pro, mounted on a tripod, with some lights and a green screen.” Evan also stated that future improvements would eliminate the need for green screens by using artificial intelligence to chroma key out the green screen.
Notably, Nextech added AiR Show to its growing list of AR brands in the last quarter of 2020 following an acquisition closed on October 1, 2020. At the time, AiR Show, which was previously owned by TRICK 3D, was primarily used in the music industry. It enabled users to purchase tickets to watch performances from music artists and other people in the comfort of their homes (https://ibn.fm/CwQkh). But Nextech has since expanded this focus to encompass other industries, including automotive, medical, dating, fashion shows (apparel), education and art (for instance, during auctions).
“You can beam in a professor from any top school all over the globe,” Evan continued. “This technology could be used to holoport teachers from cities to rural areas, where they normally wouldn’t be able to get access to that kind of education. So, it could be a gamechanger for some countries as far as education.”
Nextech views AiR Show as an opportunity to gain more AR revenue and increase its earnings potential in its fast-growing AR business. The purchase of AiR Show late last year was the company’s seventh acquisition and grew its portfolio of AR applications to three. It was part of a strategy to bring together various AR offerings to create the world’s first complete AR ecosystem. With the roll-out of improvements, such as the holoportation technology, Nextech is inching closer to realizing this strategy by availing a product suitable for use in different industries.
The company is also looking into using NFT technology in combination with its AR and AirShow app.
For more information, visit the company’s website at www.NextechAR.com.
NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Splash Beverage Group Inc. (SBEV) Expands TapouT Product Line to Alabama, Florida
SBEV inks agreements with Gulf Distributing of Florida, Alabama—one of area’s most-established distributors
TapouT is first advanced-performance drink that focuses on all three levels of physical support: activation, hydration and recovery
Splash Beverage Group (OTCQB: SBEV), a holding company of leading portfolio of beverage brands, is expanding the reach of its TapouT performance drink into Alabama and Florida. Splash has finalized agreements with Gulf Distributing of Florida and Gulf Distributing of Alabama to distribute TapouT beverages, its complete line of high-performance sports drink that contain a proprietary blend of essential vitamins, minerals and electrolytes (https://ibn.fm/wjqw2).
“We have a 20-year relationship with Gulf Distribution and we are extremely excited to be working with their team again,” said Splash Beverage CEO Robert Nistico. “Our brand TapouT joins their blue-chip portfolio of Coors, Heineken, Corona, Red Bull, Essentia Water, 7-Up and Snapple, with statewide coverage in Alabama, including TapouT’s new authorization of 74 MapCo stores in the state. . . . This adds to TapouT’s rapidly growing list of distributors in Southeast United States, particularly in Florida as they will cover Bay, Calhoun, Escambia, Gulf, Holmes, Jackson, Okaloosa, Santa Rosa, Walton and Washington counties.”
The two divisions of Gulf Distributing Holdings (“GDH”) manage and operate seven individual beverage distributors that encompass central and southern Alabama and the panhandle of Florida. One of the most-established distributors in the area, GDH in its entirety represents more than 100 suppliers and services more than 10,000 retail accounts in the Southeastern United States.
TapouT is the first advanced-performance drink that focuses on all three levels of physical support — activation, hydration and recovery resulting in increased endurance and performance. The line features a proprietary blend of nine essential vitamins, five minerals and all five electrolytes that are formulated for maximum absorption to enhance cellular health and function. The beverages offer tasty, light and refreshing flavors.
The current Splash portfolio features four unique beverage brands. In addition to its TapoutT performance drinks, the company offers Salt Naturally Flavored Tequila, a 100% blanco agave 80-proof tequila that offers a clean and delicate taste; Copa Di Vino, the leading producer of premium “wine by the glass” in the country; and Pulpoloco Sangria, a premium-crafted sangria imported from Spain. Each of these brands offers one or more of the qualities that the company specifically seeks in an acquisition.
Specializing in manufacturing, distributing, sales and marketing of various beverages across multiple channels, Splash operates in both the alcoholic and nonalcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and accelerate pre-existing brands to exit for cash events. The company’s management team has invaluable expertise and insight, and the company strives to identify brands it perceives to have highly visible preexisting brand awareness or pure category innovation.
Specifically, the company look for brands and products that are on trend and deliver natural quality, health benefits, freshness and refreshment within their beverages. The company looks to maintain highest performance standards and focus on execution as it works with distributors and retail partners achieve and exceed all goals. In addition, the company offers support for members of the U.S. armed forces, first responders and health-care professionals.
NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
According to the recently published results of a poll, at least two-thirds of voters in Louisiana support the full legalization of cannabis, both for recreational and medical use. These voters include the majority of the Republicans in the state, according to the poll.
This recent survey, conducted by JMC Enterprises, indicates that support for marijuana legalization in the state has risen significantly from the time a similar poll was done. For example, only 54% of the voters expressed support for legalization last year compared to the 67% who now say they would prefer to see cannabis legalized.
In this recent poll, only 16% of the people sampled admitted that they wouldn’t want to see marijuana legalized in Louisiana for recreational use, but they would support legalization for medicinal use. Just 8% expressed opposition to both medical and recreational use legalization.
As has been the case previously, Democrats lead the surge of supporters of cannabis legalization. The JMC poll, not surprisingly, shows that 67% of all Democrats support recreational marijuana legalization compared to 58% of Republicans who support the policy change. Youth are particularly bullish on the subject with 93% of all younger voters saying they would like to see marijuana legalized not only for medical but for recreational use as well.
During the same poll, voters were asked to express their thoughts about changing cannabis policy so that people are fined for marijuana possession or use instead of serving time in jail. Nearly half of the respondents said they preferred full legalization rather than decriminalization. Only 27% said removing criminal penalties would be preferred in lieu of full legalization.
At the moment, the marijuana laws in the state only allow patients enrolled in the medical marijuana program access a limited range of cannabis products. An estimated 75% of those who took part in the JMC poll want this to change so that patients have access to a wider variety of products, including the entire marijuana plant.
Last year, Gov. John B. Edwards appended his signature to a bill geared at expanding the state’s medical cannabis program so that licensed physicians could prescribe medical marijuana for any patient suffering from a debilitating condition. Previously, physicians could only recommend medical marijuana as a treatment for a narrowly defined list of conditions and diseases.
JMC Enterprises polled a total of 1,160 voters in the state March 22–23. The findings represent the latest views of registered voters in the state. It remains to be seen how these results will influence policy in the coming years.
As the discussion on whether marijuana should or shouldn’t be legalized in different jurisdictions rages on, many companies have found success in manufacturing products from nonintoxicating ingredients of the cannabis sativa plant. For instance, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) started out selling pH-balanced drinking water, but the company has added a line of CBD-infused products to its offering, and the market has given an overwhelming positive response to those gummies, salves, tinctures and drinks.
NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
A pilot study that was conducted recently by Northwestern Medicine has discovered that when a female athlete experiences a concussion when the hormone progesterone is at its highest during her menstrual cycle phase, she experiences less stress. Experiencing less stress is a recovery marker while feeling more stress is among the symptoms of a concussion.
The study, which was reported in the “Journal of Neurotrauma,” also found that the reason for the neural protection was the increase of the flow of blood to the brain because of higher progesterone levels.
Research assistant professor of behavioral sciences and psychiatry from the Northwestern University Feinberg School of Medicine Amy Herrold, who was the co-author of the study, explained that the discovery suggests that using hormonal contraceptives, which can increase progesterone artificially or right after ovulation when progesterone is at its highest, could mean that athletes would not experience serious symptoms if they experienced a concussion.
Assistant professor of radiology at Feinberg Jenny Chen, who was lead author of the study, stated that resolving the symptoms of a concussion was particularly problematic for athletes who were working on returning to sports, school and daily activities after suffering a traumatic head injury.
The athletes who participated in the research were members of tennis clubs, women’s rugby, lacrosse, triathlon, crew, ultimate Frisbee and soccer. Herrold noted that the researchers looked into club athletes as the majority of college students took part in club athletics compared to varsity athletics. Additionally, club athletics weren’t monitored as much, which could potentially lead to concussions being underreported and increased exposure.
Herrold asserted that their research filled a gap in literature, as a majority of concussion research associated with sports mainly looked into the effects of concussions on male athletes.
The researchers also discovered an increased flow of blood in the brain when a female athlete had high progesterone levels due to her menstrual cycle phase.
The study involved 30 female athletes who researchers evaluated three to ten days after they had experienced an mTBI or a concussion. The researchers performed an MRI scan that looked into the blood flow in the brain. This was in addition to assessing the participant’s reported mild traumatic brain injury symptoms, which were recorded in a questionnaire, and drawing blood to examine each participant’s level of progesterone.
Herrold noted that doctors should assess the use of contraceptives, which increase levels of progesterone in athletes who could be at risk of experiencing a mild TBI or a concussion, as there was a possibility for neuroprotection.
What this research team is recommending is that women athletes need a personalized approach to safeguarding them against the effects of concussion. Delivering personalized care is what Predictive Oncology (NASDAQ: POAI) brings to cancer treatment with its focus on harnessing the powers of data and AI while designing cancer treatments.
NOTE TO INVESTORS: The latest news and updates relating to Predictive Oncology (NASDAQ: POAI) are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
